https://www.fool.com/investing/2024/04/28/canopy-growth-obtains-shareholder-approval-to-move/?source=iedfolrf0000001
Apr 28, 2024 - Is Canopy Growth closer to entering the U.S. cannabis market?
0
fool:-5954027437638936782
0
https://www.zacks.com/stock/news/2215032/nasdaq-ndaq-reports-next-week-wall-street-expects-earnings-growth?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_9-2215032
Jan 24, 2024 - Nasdaq (NDAQ) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
zc:4181929339262288537
0
https://www.zacks.com/stock/news/2216380/how-to-find-strong-finance-stocks-slated-for-positive-earnings-surprises?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_earnings_esp-2216380
Jan 26, 2024 - Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
zc:-1966554462358204595
0
https://www.zacks.com/stock/news/2216418/what-analyst-projections-for-key-metrics-reveal-about-nasdaq-ndaq-q4-earnings?cid=CS-ZC-FT-fundamental_analysis|nfm_preview-2216418
Jan 26, 2024 - Beyond analysts' top -and-bottom-line estimates for Nasdaq (NDAQ), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended December 2023.
zc:-3240443995904260982
0
https://www.zacks.com/stock/news/2226196/cme-group-cme-q4-earnings-revenues-surpass-estimates?cid=CS-ZC-FT-analyst_blog|earnings_article-2226196
Feb 14, 2024 - CME Group's (CME) fourth-quarter results reflect higher revenues and increased average daily volume in five of its six asset classes, partially offset by higher expenses.
zc:-2130107594638824578
0
https://www.zacks.com/stock/news/2228039/coinbase-coin-stock-on-the-rise-since-q4-earnings-beat?cid=CS-ZC-FT-analyst_blog|earnings_article-2228039
Feb 19, 2024 - Coinbase (COIN) fourth-quarter results reflect significant growth in subscription and services revenues as well as low expenses.
zc:1349623264549350282
0
https://www.zacks.com/stock/news/2241508/cme-cme-up-4-since-last-earnings-report-can-it-continue?cid=CS-ZC-FT-realtime_blog-2241508
Mar 15, 2024 - CME (CME) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
zc:3499655942229841242
0
https://www.zacks.com/stock/news/2253544/will-nasdaq-ndaq-beat-estimates-again-in-its-next-earnings-report?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_7-2253544
Apr 10, 2024 - Nasdaq (NDAQ) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
zc:3045440830753535023
0
https://www.zacks.com/stock/news/2253597/here-s-why-you-should-stay-invested-in-nasdaq-ndaq-stock?cid=CS-ZC-FT-analyst_blog|rank_focused-2253597
Apr 10, 2024 - Organic growth, ramping up of on-trading revenue base, strategic buyouts and effective capital deployment poise Nasdaq (NDAQ) for growth.
zc:3816534468720585733
0
https://www.zacks.com/stock/news/2201672/here-s-why-you-should-stay-invested-in-nasdaq-ndaq-stock?cid=CS-ZC-FT-analyst_blog|rank_focused-2201672
Dec 22, 2023 - An impressive organic growth, ramping up of on-trading revenue base, strategic buyouts to capitalize on growing market opportunities and effective capital deployment poise Nasdaq (NDAQ) for growth.
zc:-7457760881883261784
0